Table 2.
Clinical characteristics and diagnostic work-up for MG of our patients at the moment of myasthenia diagnosis
|
Case No. |
Patient’s age at thymectomy [years] |
Gender |
MG – history and work-up study |
|||
|
Length of time between MG diagnosis and thymectomy |
MG type |
Anti-AChR antibody [nmol/dL]* |
Electromyographic decrement# |
|||
|
1. |
54 |
F |
4 years |
IVA |
12 |
25% |
|
2. |
28 |
F |
6 months |
IIIA |
6 |
62% |
|
3. |
60 |
F |
8 years |
IIIA |
16 |
32% |
|
4. |
19 |
M |
1 year |
I |
4 |
20% |
AChR: Acetylcholine receptor; F: Female; M: Male; MG: Myasthenia gravis [MG Foundation of America (MGFA) class]. *Normal range: ≤0.25 nmol/dL; #Normal muscle produces a decrement up to 8%